London, United Kingdom

Duncan I Jodrell

This inventor holds 1 USPTO granted patent. Top assignee: British Technology Group Limited. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Duncan I Jodrell. Retrieved from https://idiyas.com/inventor/duncan-i-jodrell

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Duncan I Jodrell: Innovator in Anti-Cancer Compounds

Introduction

Duncan I Jodrell is a notable inventor based in London, GB. He has made significant contributions to the field of anti-cancer research. His innovative work has led to the development of a patent that addresses critical challenges in cancer treatment.

Latest Patents

Duncan holds 1 patent for his work on anti-cancer compounds. This patent reflects his commitment to advancing medical science and improving patient outcomes.

Career Highlights

Duncan is associated with the British Technology Group Limited, where he applies his expertise in developing groundbreaking technologies. His role in this organization has allowed him to focus on innovative solutions in the healthcare sector.

Collaborations

Throughout his career, Duncan has collaborated with esteemed colleagues such as Graham M Bisset and Ann L Jackman. These partnerships have fostered a collaborative environment that enhances the potential for innovation.

Conclusion

Duncan I Jodrell's contributions to anti-cancer research exemplify the impact of innovation in medicine. His work continues to inspire advancements in cancer treatment and showcases the importance of collaboration in scientific endeavors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…